Back to search

Immunotherapy with OX40L‐Fc or anti‐CTLA‐4 enhances local tissue responses and killing of Leishmania donovani

Data up to Jan 2025

Published2004
Citations82
References38

Total Citations Per Year

Abstract

References (38)

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

2002 • 1,733 citations

Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

1999 • 1,000 citations

CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy

2001 • 964 citations

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

2002 • 777 citations

OX40 Promotes Bcl-xL and Bcl-2 Expression and Is Essential for Long-Term Survival of CD4 T Cells

2001 • 638 citations

The Emerging Role of CTLA-4 as an Immune Attenuator

1997 • 637 citations

The Role of CD40 Ligand in Costimulation and T‐Cell Activation

1996 • 441 citations

The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function

2001 • 413 citations

Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity

2000 • 386 citations

Chemotherapy of Leishmaniasis

2002 • 378 citations

Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy

2002 • 246 citations

CD4+ regulatory T cells

2001 • 241 citations

Tissue granuloma structure‐function in experimental visceral leishmaniasis

2001 • 200 citations

B Cell-Deficient Mice Are Highly Resistant to Leishmania donovani Infection, but Develop Neutrophil-Mediated Tissue Pathology

2000 • 194 citations

Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines

2001 • 184 citations

Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis

2002 • 177 citations

Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control ofLeishmania donovani

1998 • 166 citations

Intracellular Antimicrobial Activity in the Absence of Interferon-γ: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-γ Gene-disrupted Mice

1997 • 162 citations

The Early IL-4 Response toLeishmania majorand the Resulting Th2 Cell Maturation Steering Progressive Disease in BALB/c Mice Are Subject to the Control of Regulatory CD4+CD25+ T Cells

2002 • 146 citations

Blockade of CTLA-4 Enhances Host Resistance to the Intracellular Pathogen,Leishmania donovani

1998 • 135 citations

A Role for Tumor Necrosis Factor-α in Remodeling the Splenic Marginal Zone during Leishmania donovani Infection

2002 • 124 citations

Deficient expression of co‐stimulatory molecules on Leishmania‐infected macrophages

1994 • 123 citations

Negative Regulation of T Cell Receptor–Lipid Raft Interaction by Cytotoxic T Lymphocyte–associated Antigen 4

2003 • 122 citations

Interleukin‐12 Regulates the Response to Chemotherapy in Experimental Visceral Leishmaniasis

2000 • 115 citations

OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines

2002 • 112 citations

TGF-β Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar

2000 • 104 citations

Macrophage‐T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania‐infected macrophages and its implication in the suppression of cell‐mediated immunity

1995 • 95 citations

Oral treatment of visceral leishmaniasis with miltefosine

1999 • 94 citations

Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134)

2002 • 90 citations

Induction of Anti-Mammary Cancer Immunity by Engaging the OX-40 Receptor in Vivo

2001 • 80 citations

Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor

2001 • 78 citations

Effect of Continuous Administration of Interferon- in Experimental Visceral Leishmaniasis

1990 • 69 citations

Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis

2003 • 64 citations

CD95 is required for the early control of parasite burden in the liver ofLeishmania donovani-infected mice

2001 • 57 citations

Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation

2001 • 57 citations

Anin VivoAnalysis of Cytokine Production duringLeishmania donovaniInfection inscidMice

1996 • 52 citations

OX40 Ligation on Activated T Cells Enhances the Control ofCryptococcus neoformansand Reduces Pulmonary Eosinophilia

2003 • 46 citations

Novel therapeutics for the treatment of graft-versus-host disease

2002 • 29 citations

Cited By (0)

Loading...
Immunotherapy with OX40L‐Fc or anti‐CTLA‐4 enhances local tissue responses and killing of… (2004) – European Journal of Immunology | Metascience Observatory Explorer